Presbyopia developed earlier during the COVID-19 pandemic

<h4>Purpose</h4> The aim of this cohort study was to evaluate the development and progression of presbyopia and the status of dry eye-related symptoms from 2017 to 2020, to assess the impact of the COVID-19 pandemic. <h4>Methods</h4> Near add power at 30 cm was measured in 33...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kazuno Negishi, Masahiko Ayaki
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/83b6f75eea724546b66e2f247aad4cb1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:83b6f75eea724546b66e2f247aad4cb1
record_format	dspace
spelling	oai:doaj.org-article:83b6f75eea724546b66e2f247aad4cb12021-11-18T08:14:35ZPresbyopia developed earlier during the COVID-19 pandemic1932-6203https://doaj.org/article/83b6f75eea724546b66e2f247aad4cb12021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584719/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Purpose</h4> The aim of this cohort study was to evaluate the development and progression of presbyopia and the status of dry eye-related symptoms from 2017 to 2020, to assess the impact of the COVID-19 pandemic. <h4>Methods</h4> Near add power at 30 cm was measured in 339 participants aged between 40 and 55 from 2017 to 2021 at Japanese eye clinics. Regression analysis of near add power and age was analyzed to compare 2017 with later years up to the pandemic. The prevalence of dry eye-related signs and six common symptoms were compared. <h4>Results</h4> The number and mean age (y) of participants were 183 (48.6±4.1) in 2017, 46 (51.3±7.5) in 2019, and 110 (49.2±3.7) in 2020–21, respectively. The mean progression rate of near add power (D/y) was 0.13 for 2017, 0.09 for 2019 (P = 0.028, vs 2017), and 0.08 for 2020–21 (P<0.001, vs 2017). The slope (rate of presbyopia progression) became flatter from 2017 to 2021 and the estimated near add power at the age of 40 increased from 2017 to 2020–2021, implicating presbyopia developed earlier and worsened during the study period. The 2017 values were comparable with previous studies described in 1922 and 2019. The standardized correlation coefficient between age and near add power was 0.816 for 2017, 0.671 for 2019 (P = 0.084, vs 2017), and 0.572 for 2020–21 (P<0.001, vs 2017). Multiple regression analysis revealed age and COVID-19 pandemic were significantly correlated with near add power. The prevalence of dryness irritation, and pain was greater in 2020–21 than in 2017 with no difference in the prevalence of eye fatigue, blurring, and photophobia. There was no difference in the prevalence of short tear break-up time and positive corneal staining among 2017, 2019 and 2020–21. <h4>Conclusion</h4> Estimated presbyopia developed earlier and progressed slower from 2017 to 2021, the COVID-19 pandemic. Stress and rapid digitalization related to strict infection control and quarantine might be contributing factors.Kazuno NegishiMasahiko AyakiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Kazuno Negishi Masahiko Ayaki Presbyopia developed earlier during the COVID-19 pandemic
description	<h4>Purpose</h4> The aim of this cohort study was to evaluate the development and progression of presbyopia and the status of dry eye-related symptoms from 2017 to 2020, to assess the impact of the COVID-19 pandemic. <h4>Methods</h4> Near add power at 30 cm was measured in 339 participants aged between 40 and 55 from 2017 to 2021 at Japanese eye clinics. Regression analysis of near add power and age was analyzed to compare 2017 with later years up to the pandemic. The prevalence of dry eye-related signs and six common symptoms were compared. <h4>Results</h4> The number and mean age (y) of participants were 183 (48.6±4.1) in 2017, 46 (51.3±7.5) in 2019, and 110 (49.2±3.7) in 2020–21, respectively. The mean progression rate of near add power (D/y) was 0.13 for 2017, 0.09 for 2019 (P = 0.028, vs 2017), and 0.08 for 2020–21 (P<0.001, vs 2017). The slope (rate of presbyopia progression) became flatter from 2017 to 2021 and the estimated near add power at the age of 40 increased from 2017 to 2020–2021, implicating presbyopia developed earlier and worsened during the study period. The 2017 values were comparable with previous studies described in 1922 and 2019. The standardized correlation coefficient between age and near add power was 0.816 for 2017, 0.671 for 2019 (P = 0.084, vs 2017), and 0.572 for 2020–21 (P<0.001, vs 2017). Multiple regression analysis revealed age and COVID-19 pandemic were significantly correlated with near add power. The prevalence of dryness irritation, and pain was greater in 2020–21 than in 2017 with no difference in the prevalence of eye fatigue, blurring, and photophobia. There was no difference in the prevalence of short tear break-up time and positive corneal staining among 2017, 2019 and 2020–21. <h4>Conclusion</h4> Estimated presbyopia developed earlier and progressed slower from 2017 to 2021, the COVID-19 pandemic. Stress and rapid digitalization related to strict infection control and quarantine might be contributing factors.
format	article
author	Kazuno Negishi Masahiko Ayaki
author_facet	Kazuno Negishi Masahiko Ayaki
author_sort	Kazuno Negishi
title	Presbyopia developed earlier during the COVID-19 pandemic
title_short	Presbyopia developed earlier during the COVID-19 pandemic
title_full	Presbyopia developed earlier during the COVID-19 pandemic
title_fullStr	Presbyopia developed earlier during the COVID-19 pandemic
title_full_unstemmed	Presbyopia developed earlier during the COVID-19 pandemic
title_sort	presbyopia developed earlier during the covid-19 pandemic
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/83b6f75eea724546b66e2f247aad4cb1
work_keys_str_mv	AT kazunonegishi presbyopiadevelopedearlierduringthecovid19pandemic AT masahikoayaki presbyopiadevelopedearlierduringthecovid19pandemic
_version_	1718421995860787200

Presbyopia developed earlier during the COVID-19 pandemic

Ejemplares similares